Hepatitis C virus and alcohol: Same mitotic targets but different signaling pathways
Chromosomal aberrations are frequently observed in hepatitis C virus (HCV)- and alcohol-related hepatocellular carcinomas (HCCs). The mechanisms by which chromosomal aberrations occur during hepatocarcinogenesis are still unknown. However, these aberrations are considered to be the result of deregul...
Saved in:
Published in | Journal of hepatology Vol. 54; no. 5; pp. 956 - 963 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Kidlington
Elsevier B.V
01.05.2011
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Chromosomal aberrations are frequently observed in hepatitis C virus (HCV)- and alcohol-related hepatocellular carcinomas (HCCs). The mechanisms by which chromosomal aberrations occur during hepatocarcinogenesis are still unknown. However, these aberrations are considered to be the result of deregulation of some mitotic proteins, including the alteration of Cyclin B1 and Aurora kinase A expression, and the phosphorylation of gamma-tubulin. Our study aims at investigating changes in expression of the above mentioned proteins and related intracellular pathways, in in vitro and in vivo models of both HCV- and alcohol- dependent HCCs.
In this study, the molecular defects and the mechanisms involved in deregulation of the mitotic machinery were analyzed in human hepatoma cells, expressing HCV proteins treated or not with ethanol, and in liver tissues from control subjects (n=10) and patients with HCV- (n=10) or alcohol-related (n=10) HCCs.
Expression of Cyclin B1, Aurora kinase A, and tyrosine-phosphorylated gamma-tubulin was analyzed in models reproducing HCV infection and ethanol treatment in HCC cells. Interestingly, HCV and alcohol increased the expression of Cyclin B, Aurora kinase A, and tyrosine-phosphorylated gamma-tubulin also in tissues from patients with HCV- or alcohol-related HCCs. In vitro models suggest that HCV requires the expression of PKR (RNA-activated protein kinase), as well as JNK (c-Jun N-terminal kinase) and p38MAPK (p38 mitogen-activated protein kinase) proteins; while, ethanol bypasses all these pathways.
Our results support the idea that HCV and alcohol may promote oncogenesis by acting through the same mitotic proteins, but via different signaling pathways. |
---|---|
AbstractList | Chromosomal aberrations are frequently observed in hepatitis C virus (HCV)- and alcohol-related hepatocellular carcinomas (HCCs). The mechanisms by which chromosomal aberrations occur during hepatocarcinogenesis are still unknown. However, these aberrations are considered to be the result of deregulation of some mitotic proteins, including the alteration of Cyclin B1 and Aurora kinase A expression, and the phosphorylation of gamma-tubulin. Our study aims at investigating changes in expression of the above mentioned proteins and related intracellular pathways, in in vitro and in vivo models of both HCV- and alcohol- dependent HCCs.BACKGROUND & AIMSChromosomal aberrations are frequently observed in hepatitis C virus (HCV)- and alcohol-related hepatocellular carcinomas (HCCs). The mechanisms by which chromosomal aberrations occur during hepatocarcinogenesis are still unknown. However, these aberrations are considered to be the result of deregulation of some mitotic proteins, including the alteration of Cyclin B1 and Aurora kinase A expression, and the phosphorylation of gamma-tubulin. Our study aims at investigating changes in expression of the above mentioned proteins and related intracellular pathways, in in vitro and in vivo models of both HCV- and alcohol- dependent HCCs.In this study, the molecular defects and the mechanisms involved in deregulation of the mitotic machinery were analyzed in human hepatoma cells, expressing HCV proteins treated or not with ethanol, and in liver tissues from control subjects (n=10) and patients with HCV- (n=10) or alcohol-related (n=10) HCCs.METHODSIn this study, the molecular defects and the mechanisms involved in deregulation of the mitotic machinery were analyzed in human hepatoma cells, expressing HCV proteins treated or not with ethanol, and in liver tissues from control subjects (n=10) and patients with HCV- (n=10) or alcohol-related (n=10) HCCs.Expression of Cyclin B1, Aurora kinase A, and tyrosine-phosphorylated gamma-tubulin was analyzed in models reproducing HCV infection and ethanol treatment in HCC cells. Interestingly, HCV and alcohol increased the expression of Cyclin B, Aurora kinase A, and tyrosine-phosphorylated gamma-tubulin also in tissues from patients with HCV- or alcohol-related HCCs. In vitro models suggest that HCV requires the expression of PKR (RNA-activated protein kinase), as well as JNK (c-Jun N-terminal kinase) and p38MAPK (p38 mitogen-activated protein kinase) proteins; while, ethanol bypasses all these pathways.RESULTSExpression of Cyclin B1, Aurora kinase A, and tyrosine-phosphorylated gamma-tubulin was analyzed in models reproducing HCV infection and ethanol treatment in HCC cells. Interestingly, HCV and alcohol increased the expression of Cyclin B, Aurora kinase A, and tyrosine-phosphorylated gamma-tubulin also in tissues from patients with HCV- or alcohol-related HCCs. In vitro models suggest that HCV requires the expression of PKR (RNA-activated protein kinase), as well as JNK (c-Jun N-terminal kinase) and p38MAPK (p38 mitogen-activated protein kinase) proteins; while, ethanol bypasses all these pathways.Our results support the idea that HCV and alcohol may promote oncogenesis by acting through the same mitotic proteins, but via different signaling pathways.CONCLUSIONSOur results support the idea that HCV and alcohol may promote oncogenesis by acting through the same mitotic proteins, but via different signaling pathways. Chromosomal aberrations are frequently observed in hepatitis C virus (HCV)- and alcohol-related hepatocellular carcinomas (HCCs). The mechanisms by which chromosomal aberrations occur during hepatocarcinogenesis are still unknown. However, these aberrations are considered to be the result of deregulation of some mitotic proteins, including the alteration of Cyclin B1 and Aurora kinase A expression, and the phosphorylation of gamma-tubulin. Our study aims at investigating changes in expression of the above mentioned proteins and related intracellular pathways, in in vitro and in vivo models of both HCV- and alcohol- dependent HCCs. In this study, the molecular defects and the mechanisms involved in deregulation of the mitotic machinery were analyzed in human hepatoma cells, expressing HCV proteins treated or not with ethanol, and in liver tissues from control subjects (n=10) and patients with HCV- (n=10) or alcohol-related (n=10) HCCs. Expression of Cyclin B1, Aurora kinase A, and tyrosine-phosphorylated gamma-tubulin was analyzed in models reproducing HCV infection and ethanol treatment in HCC cells. Interestingly, HCV and alcohol increased the expression of Cyclin B, Aurora kinase A, and tyrosine-phosphorylated gamma-tubulin also in tissues from patients with HCV- or alcohol-related HCCs. In vitro models suggest that HCV requires the expression of PKR (RNA-activated protein kinase), as well as JNK (c-Jun N-terminal kinase) and p38MAPK (p38 mitogen-activated protein kinase) proteins; while, ethanol bypasses all these pathways. Our results support the idea that HCV and alcohol may promote oncogenesis by acting through the same mitotic proteins, but via different signaling pathways. Background & Aims Chromosomal aberrations are frequently observed in hepatitis C virus (HCV)- and alcohol-related hepatocellular carcinomas (HCCs). The mechanisms by which chromosomal aberrations occur during hepatocarcinogenesis are still unknown. However, these aberrations are considered to be the result of deregulation of some mitotic proteins, including the alteration of Cyclin B1 and Aurora kinase A expression, and the phosphorylation of gamma-tubulin. Our study aims at investigating changes in expression of the above mentioned proteins and related intracellular pathways, in in vitro and in vivo models of both HCV- and alcohol- dependent HCCs. Methods In this study, the molecular defects and the mechanisms involved in deregulation of the mitotic machinery were analyzed in human hepatoma cells, expressing HCV proteins treated or not with ethanol, and in liver tissues from control subjects ( n = 10) and patients with HCV- ( n = 10) or alcohol-related ( n = 10) HCCs. Results Expression of Cyclin B1, Aurora kinase A, and tyrosine-phosphorylated gamma-tubulin was analyzed in models reproducing HCV infection and ethanol treatment in HCC cells. Interestingly, HCV and alcohol increased the expression of Cyclin B, Aurora kinase A, and tyrosine-phosphorylated gamma-tubulin also in tissues from patients with HCV- or alcohol-related HCCs. In vitro models suggest that HCV requires the expression of PKR (RNA-activated protein kinase), as well as JNK (c-Jun N-terminal kinase) and p38MAPK (p38 mitogen-activated protein kinase) proteins; while, ethanol bypasses all these pathways. Conclusions Our results support the idea that HCV and alcohol may promote oncogenesis by acting through the same mitotic proteins, but via different signaling pathways. |
Author | Ghidinelli, Monica Zerbini, Alessandro Balsano, Clara Alisi, Anna Missale, Gabriele |
Author_xml | – sequence: 1 givenname: Anna surname: Alisi fullname: Alisi, Anna organization: Laboratory of Molecular Virology and Oncology, Fondazione A. Cesalpino, University of Rome, Rome, V. le del Policlinico 155, 00161 Rome, Italy – sequence: 2 givenname: Monica surname: Ghidinelli fullname: Ghidinelli, Monica organization: Laboratory of Molecular Virology and Oncology, Fondazione A. Cesalpino, University of Rome, Rome, V. le del Policlinico 155, 00161 Rome, Italy – sequence: 3 givenname: Alessandro surname: Zerbini fullname: Zerbini, Alessandro organization: Laboratory of Viral Immunopathology, Azienda Ospedaliero, Universitaria di Parma, Via Gramsci 14, 43100 Parma, Italy – sequence: 4 givenname: Gabriele surname: Missale fullname: Missale, Gabriele organization: Laboratory of Viral Immunopathology, Azienda Ospedaliero, Universitaria di Parma, Via Gramsci 14, 43100 Parma, Italy – sequence: 5 givenname: Clara surname: Balsano fullname: Balsano, Clara email: clara.balsano@uniroma1.it organization: Laboratory of Molecular Virology and Oncology, Fondazione A. Cesalpino, University of Rome, Rome, V. le del Policlinico 155, 00161 Rome, Italy |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24073396$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21145809$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUlFrFDEYDFKx1-of8EHyIj7t-SW7m2SLCHJUKxR8aH0Oafbbu6x7mzPJVu7fN8tdEQrWp8AwM-GbmTNyMvoRCXnLYMmAiY_9st_gbskhA6CWGXpBFkwAFCAqdkIWGVGF4lKdkrMYewAooalekVPOWFUraBbk9gp3JrnkIl3RexemSM3YUjNYv_HDBb0xW6Rbl3xyliYT1pgivZsSbV3XYcAx0ejWoxncuKbZafPH7ONr8rIzQ8Q3x_ec_Px6ebu6Kq5_fPu--nJd2LqWqUDWgWESrAHG204qbmpZNVVXoxVSta3laFndSNZU0lYMLAohO8GthZLJtjwnHw6-u-B_TxiT3rpocRjMiH6KWgku5pvrzHx3ZE53W2z1LritCXv9GEQmvD8STLRm6IIZrYt_eRXIsmxE5qkDzwYfY8BOW5dygH5MwbhBM9BzN7rXczd67kaD0hnKUv5E-uj-rOjTQYQ5x3uHQUfrcLTYuoA26da75-Wfn8htbsrlC3_hHmPvp5C7i5rpyDXom3kx82BY3krDxBzcxb8N_vf7A15Ezzo |
CODEN | JOHEEC |
CitedBy_id | crossref_primary_10_3233_CBM_190507 crossref_primary_10_17795_ajcmi_19212 crossref_primary_10_1097_SLA_0b013e31829291e9 crossref_primary_10_1016_j_compbiomed_2014_12_003 crossref_primary_10_3390_ijms23179679 crossref_primary_10_1016_j_cyto_2013_01_007 crossref_primary_10_1002_hep_26767 crossref_primary_10_1007_s13277_014_2007_9 crossref_primary_10_1007_s13258_016_0428_0 crossref_primary_10_2174_1574893617666220408085955 crossref_primary_10_1016_S1665_2681_19_31422_X crossref_primary_10_1111_j_1872_034X_2011_00818_x crossref_primary_10_1038_onc_2012_382 |
Cites_doi | 10.1016/j.biocel.2006.08.006 10.1038/nrc2248 10.1053/j.gastro.2006.09.014 10.1055/s-2004-832942 10.1016/j.canlet.2008.10.011 10.1136/gut.44.6.874 10.1002/hep.22194 10.1158/1541-7786.MCR-06-0208 10.1111/j.1572-0241.2008.01948.x 10.1111/j.1349-7006.2008.01006.x 10.1016/S1665-2681(19)32034-4 10.1159/000012140 10.1093/emboj/19.16.4292 10.1053/j.gastro.2004.09.020 10.1002/hep.23594 10.1053/jhep.2003.50332 10.1074/jbc.M512536200 10.1074/jbc.M802751200 10.1016/j.etp.2009.08.006 10.1128/JVI.00224-09 10.1053/jhep.2002.36780 10.1111/j.1440-1746.2007.05293.x 10.1158/1078-0432.CCR-1057-03 10.1038/sj.onc.1207374 10.1021/bi8005225 10.1038/sj.onc.1209906 10.1053/j.seminoncol.2006.04.007 10.1002/hep.20847 10.1002/hep.20957 10.3748/wjg.v13.i37.4955 10.1007/s00894-004-0218-5 10.1111/j.1478-3231.2007.01652.x 10.1242/jcs.013136 10.1016/S0016-5085(03)00290-7 10.2174/157339406775471830 10.1136/gut.51.1.132 10.1073/pnas.0305817101 10.1091/mbc.E05-07-0621 10.1002/jcp.20363 10.1016/j.bbrc.2009.10.153 10.1016/S0092-8674(03)00642-1 10.1111/j.1440-1746.2007.05292.x 10.1158/0008-5472.CAN-06-0077 10.3748/wjg.15.4753 |
ContentType | Journal Article |
Copyright | 2011 2015 INIST-CNRS Copyright © 2011. Published by Elsevier B.V. |
Copyright_xml | – notice: 2011 – notice: 2015 INIST-CNRS – notice: Copyright © 2011. Published by Elsevier B.V. |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.jhep.2010.08.016 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1600-0641 |
EndPage | 963 |
ExternalDocumentID | 21145809 24073396 10_1016_j_jhep_2010_08_016 S0168827810009165 1_s2_0_S0168827810009165 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29K 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACIUM ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 D-I DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDZ HMK HMO HVGLF HX~ HZ~ IHE J1W KOM LZ1 M27 M41 MJL MO0 N9A O-L O9- OAUVE OC. ON0 OVD OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K TEORI UV1 WUQ X7M YOC Z5R ZGI ~G- AACTN AFCTW AFKWA AJOXV AMFUW RIG AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR AAYXX AGRNS CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c557t-e1f0a170ca012df782a57494f5ec678ddc2ec15971947c410ce667f62cc0317d3 |
IEDL.DBID | .~1 |
ISSN | 0168-8278 1600-0641 |
IngestDate | Fri Jul 11 05:15:25 EDT 2025 Wed Feb 19 01:47:30 EST 2025 Wed Apr 02 07:17:08 EDT 2025 Thu Apr 24 23:04:31 EDT 2025 Tue Jul 01 04:14:18 EDT 2025 Fri Feb 23 02:26:41 EST 2024 Sun Feb 23 10:19:32 EST 2025 Tue Aug 26 17:21:14 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Ethanol JNK NF-kB HCC HCCs siRNA NASH Cyclin B1 FAK PI3K PKR HCV HBV Aurora kinase A p38MAPK nuclear factor-kB hepatitis B virus hepatocellular carcinomas hepatitis C virus small interference RNA RNA-activated protein kinase c-Jun N-terminal kinase focal adhesion kinase p38 mitogen-activated protein kinase phosphatydil-inositol-3 kinase non-alcoholic steatohepatitis Enzyme Transferases Cyclin Hepatic disease Alcohol Hepatocellular carcinoma Malignant tumor Cyclin B1: Ethanol Virus Kinase Gastroenterology Digestive diseases Flaviviridae Hepatitis C virus Hepacivirus Cancer |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 Copyright © 2011. Published by Elsevier B.V. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c557t-e1f0a170ca012df782a57494f5ec678ddc2ec15971947c410ce667f62cc0317d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 21145809 |
PQID | 862600305 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_862600305 pubmed_primary_21145809 pascalfrancis_primary_24073396 crossref_citationtrail_10_1016_j_jhep_2010_08_016 crossref_primary_10_1016_j_jhep_2010_08_016 elsevier_sciencedirect_doi_10_1016_j_jhep_2010_08_016 elsevier_clinicalkeyesjournals_1_s2_0_S0168827810009165 elsevier_clinicalkey_doi_10_1016_j_jhep_2010_08_016 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2011-05-01 |
PublicationDateYYYYMMDD | 2011-05-01 |
PublicationDate_xml | – month: 05 year: 2011 text: 2011-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Kidlington |
PublicationPlace_xml | – name: Kidlington – name: Netherlands |
PublicationTitle | Journal of hepatology |
PublicationTitleAlternate | J Hepatol |
PublicationYear | 2011 |
Publisher | Elsevier B.V Elsevier |
Publisher_xml | – name: Elsevier B.V – name: Elsevier |
References | Ito, Takeda, Sakon, Monden, Tsujimoto, Matsuura (b0075) 2000; 59 Jeng, Peng, Lin, Hsu (b0080) 2004; 10 Teoh, Dan, Swisshelm, Lehman, Wright, Haque (b0055) 2008; 47 Spaziani, Alisi, Sanna, Balsano (b0095) 2006; 281 Li, Chen, Li, Zhang, Chen, Wang (b0150) 2005; 16 Dey, Cederbaum (b0110) 2006; 43 Qin, Tong, Song, Xue, Fan, Zhan (b0180) 2009; 275 Tanaka, Arii (b0220) 2009; 100 Löbrich, Jeggo (b0065) 2007; 7 Warner, Gray, Von Hoff (b0225) 2006; 33 Clemens (b0115) 2007; 13 Olsen, Bjørling-Poulsen, Guerra (b0160) 2007; 39 Bhadauria (b0205) 2010; 62 Hirota, Kunitoku, Sasayama, Marumoto, Zhang, Nitta (b0135) 2003; 114 Bedogni, Miglioli, Masutti, Ferri, Castiglione, Lenzi (b0125) 2008; 103 Clemens, Calisto, Sorrell, Tuma (b0100) 2003; 38 Hassan, Hwang, Hatten, Swaim, Li, Abbruzzese (b0040) 2002; 36 Alisi, Mele, Spaziani, Tavolaro, Palescandolo, Balsano (b0090) 2005; 205 Tan, Yeh, Liu, Cheung, Chen (b0020) 2008; 28 Hsu, Hsu, Tsai, Shieh, Huang, Wan (b0215) 2010; 392 Stickel, Schuppan, Hahn, Seitz (b0105) 2002; 51 Starley, Calcagno, Harrison (b0015) 2010; 51 Miller, Menthena, Chatterjee, Verdier-Pinard, Novikoff, Horwitz (b0085) 2008; 47 Morgan, Mandayam, Jamal (b0010) 2004; 127 Safdar, Schiff (b0030) 2004; 24 Rakotomalala, Studach, Wang, Gregori, Hullinger, Andrisani (b0145) 2008; 283 Motola-Kuba, Zamora-Valdes, Uribe, Mendez-Sanchez (b0005) 2006; 5 Goh, deVeer, Williams (b0190) 2000; 19 Llovet, Chen, Wurmbach, Roayaie, Fiel, Schwartz (b0175) 2006; 131 Takada, Ichikawa, Pataer, Swisher, Aggarwal (b0195) 2007; 26 Zhang, Langland, Jacobs, Samuel (b0200) 2009; 83 Bharadwaj, Yu (b0060) 2004; 23 Huang, Shen, Shui, Wenk, Ong (b0155) 2006; 66 Ito, Takeda, Sakon, Monden, Tsujimoto, Matsuura (b0170) 2000; 59 Yu, Yuan, Lu (b0025) 2008; 23 Fu, Bian, Jiang, Zhang (b0185) 2007; 5 Wilkens, Flemming, Gebel, Bleck, Terkamp, Wingen (b0045) 2004; 101 Fourest-Lieuvin, Peris, Gache, Garcia-Saez, Juillan-Binard, Lantez (b0070) 2006; 17 Plentz, Schlegelberger, Flemming, Gebel, Kreipe, Manns (b0050) 2005; 42 Blindenbacher, Duong, Hunziker, Stutvoet, Wang, Terracciano (b0140) 2003; 124 Dong, Jia, Zhang, Li, Geng, Zhou (b0210) 2009; 15 Barr, Gergely (b0130) 2007; 120 Bellentani, Pozzato, Saccoccio, Crovatto, Crocè, Mazzoran (b0035) 1999; 44 Balsano, Alisi (b0120) 2006; 2 Koike, Tsutsumi, Miyoshi, Shinzawa, Shintani, Fujie (b0165) 2008; 23 Clemens (10.1016/j.jhep.2010.08.016_b0115) 2007; 13 Warner (10.1016/j.jhep.2010.08.016_b0225) 2006; 33 Balsano (10.1016/j.jhep.2010.08.016_b0120) 2006; 2 Olsen (10.1016/j.jhep.2010.08.016_b0160) 2007; 39 Tan (10.1016/j.jhep.2010.08.016_b0020) 2008; 28 Fu (10.1016/j.jhep.2010.08.016_b0185) 2007; 5 Zhang (10.1016/j.jhep.2010.08.016_b0200) 2009; 83 Huang (10.1016/j.jhep.2010.08.016_b0155) 2006; 66 Miller (10.1016/j.jhep.2010.08.016_b0085) 2008; 47 Tanaka (10.1016/j.jhep.2010.08.016_b0220) 2009; 100 Clemens (10.1016/j.jhep.2010.08.016_b0100) 2003; 38 Barr (10.1016/j.jhep.2010.08.016_b0130) 2007; 120 Bellentani (10.1016/j.jhep.2010.08.016_b0035) 1999; 44 Ito (10.1016/j.jhep.2010.08.016_b0075) 2000; 59 Safdar (10.1016/j.jhep.2010.08.016_b0030) 2004; 24 Koike (10.1016/j.jhep.2010.08.016_b0165) 2008; 23 Löbrich (10.1016/j.jhep.2010.08.016_b0065) 2007; 7 Takada (10.1016/j.jhep.2010.08.016_b0195) 2007; 26 Hassan (10.1016/j.jhep.2010.08.016_b0040) 2002; 36 Llovet (10.1016/j.jhep.2010.08.016_b0175) 2006; 131 Yu (10.1016/j.jhep.2010.08.016_b0025) 2008; 23 Morgan (10.1016/j.jhep.2010.08.016_b0010) 2004; 127 Stickel (10.1016/j.jhep.2010.08.016_b0105) 2002; 51 Qin (10.1016/j.jhep.2010.08.016_b0180) 2009; 275 Li (10.1016/j.jhep.2010.08.016_b0150) 2005; 16 Blindenbacher (10.1016/j.jhep.2010.08.016_b0140) 2003; 124 Ito (10.1016/j.jhep.2010.08.016_b0170) 2000; 59 Bharadwaj (10.1016/j.jhep.2010.08.016_b0060) 2004; 23 Dong (10.1016/j.jhep.2010.08.016_b0210) 2009; 15 Hirota (10.1016/j.jhep.2010.08.016_b0135) 2003; 114 Plentz (10.1016/j.jhep.2010.08.016_b0050) 2005; 42 Bhadauria (10.1016/j.jhep.2010.08.016_b0205) 2010; 62 Starley (10.1016/j.jhep.2010.08.016_b0015) 2010; 51 Fourest-Lieuvin (10.1016/j.jhep.2010.08.016_b0070) 2006; 17 Alisi (10.1016/j.jhep.2010.08.016_b0090) 2005; 205 Bedogni (10.1016/j.jhep.2010.08.016_b0125) 2008; 103 Teoh (10.1016/j.jhep.2010.08.016_b0055) 2008; 47 Goh (10.1016/j.jhep.2010.08.016_b0190) 2000; 19 Spaziani (10.1016/j.jhep.2010.08.016_b0095) 2006; 281 Jeng (10.1016/j.jhep.2010.08.016_b0080) 2004; 10 Wilkens (10.1016/j.jhep.2010.08.016_b0045) 2004; 101 Hsu (10.1016/j.jhep.2010.08.016_b0215) 2010; 392 Dey (10.1016/j.jhep.2010.08.016_b0110) 2006; 43 Rakotomalala (10.1016/j.jhep.2010.08.016_b0145) 2008; 283 Motola-Kuba (10.1016/j.jhep.2010.08.016_b0005) 2006; 5 |
References_xml | – volume: 59 start-page: 68 year: 2000 end-page: 74 ident: b0075 article-title: Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma publication-title: Oncology – volume: 43 start-page: 63 year: 2006 end-page: 64 ident: b0110 article-title: Alcohol and oxidative liver injury publication-title: Hepatology – volume: 16 start-page: 41 year: 2005 end-page: 47 ident: b0150 article-title: Regulatory effects of emodin on NF-kappaB activation and inflammatory cytokine expression in RAW 264.7 macrophages publication-title: Int J Mol Med – volume: 26 start-page: 1201 year: 2007 end-page: 1212 ident: b0195 article-title: Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation publication-title: Oncogene – volume: 83 start-page: 5718 year: 2009 end-page: 5725 ident: b0200 article-title: Protein kinase PKR-dependent activation of mitogen-activated protein kinases occurs through mitochondrial adapter IPS-1 and is antagonized by vaccinia virus E3L publication-title: J Virol – volume: 62 start-page: 627 year: 2010 end-page: 635 ident: b0205 article-title: Dose-dependent hepatoprotective effect of emodin against acetaminophen-induced acute damage in rats publication-title: Exp Toxicol Pathol – volume: 47 start-page: 2078 year: 2008 end-page: 2088 ident: b0055 article-title: Defective DNA strand break repair causes chromosomal instability and accelerates liver carcinogenesis in mice publication-title: Hepatology – volume: 28 start-page: 175 year: 2008 end-page: 188 ident: b0020 article-title: Viral hepatocarcinogenesis: from infection to cancer publication-title: Liver Int – volume: 59 start-page: 68 year: 2000 end-page: 74 ident: b0170 article-title: Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma publication-title: Oncology – volume: 205 start-page: 25 year: 2005 end-page: 30 ident: b0090 article-title: Thr 446 phosphorylation of PKR by HCV core protein deregulates G2/M phase in HCC cells publication-title: J Cell Physiol – volume: 38 start-page: 385 year: 2003 end-page: 393 ident: b0100 article-title: Ethanol metabolism results in a G2/M cell-cycle arrest in recombinant Hep G2 cells publication-title: Hepatology – volume: 392 start-page: 473 year: 2010 end-page: 478 ident: b0215 article-title: Emodin inhibits the growth of hepatoma cells: finding the common anti-cancer pathway using Huh7, Hep3B, and HepG2 cells publication-title: Biochem Biophys Res Commun – volume: 127 start-page: 87 year: 2004 end-page: 96 ident: b0010 article-title: Alcohol and hepatocellular carcinoma publication-title: Gastroenterology – volume: 66 start-page: 5807 year: 2006 end-page: 5815 ident: b0155 article-title: Emodin inhibits tumor cell adhesion through disruption of the membrane lipid Raft-associated integrin signaling pathway publication-title: Cancer Res – volume: 283 start-page: 28729 year: 2008 end-page: 28740 ident: b0145 article-title: Hepatitis B virus X protein increases the Cdt1-to-geminin ratio inducing DNA re-replication and polyploidy publication-title: J Biol Chem – volume: 10 start-page: 2065 year: 2004 end-page: 2071 ident: b0080 article-title: Overexpression and amplification of Aurora-A in hepatocellular carcinoma publication-title: Clin Cancer Res – volume: 36 start-page: 1206 year: 2002 end-page: 1213 ident: b0040 article-title: Risk factors for hepatocellular carcinoma synergism of alcohol with viral hepatitis and diabetes mellitus publication-title: Hepatology – volume: 120 start-page: 2987 year: 2007 end-page: 2996 ident: b0130 article-title: Aurora-A: the maker and breaker of spindle poles publication-title: J Cell Sci – volume: 39 start-page: 227 year: 2007 end-page: 237 ident: b0160 article-title: Emodin negatively affects the phosphoinositide 3-kinase/AKT signalling pathway: a study on its mechanism of action publication-title: Int J Biochem Cell Biol – volume: 100 start-page: 1 year: 2009 end-page: 8 ident: b0220 article-title: Molecularly targeted therapy for hepatocellular carcinoma publication-title: Cancer Sci – volume: 23 start-page: 92 year: 2008 end-page: 97 ident: b0025 article-title: Alcohol, cofactors and the genetics of hepatocellular carcinoma publication-title: J Gastroenterol Hepatol – volume: 2 start-page: 41 year: 2006 end-page: 56 ident: b0120 article-title: HCV-related transformation and new therapeutic strategies: an update publication-title: Curr Cancer Ther Rev – volume: 23 start-page: 2016 year: 2004 end-page: 2027 ident: b0060 article-title: The spindle checkpoint, aneuploidy, and cancer publication-title: Oncogene – volume: 17 start-page: 1041 year: 2006 end-page: 1050 ident: b0070 article-title: Microtubule regulation in mitosis: tubulin phosphorylation by the cyclin-dependent kinase Cdk1 publication-title: Mol Biol Cell – volume: 19 start-page: 4292 year: 2000 end-page: 4297 ident: b0190 article-title: The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin publication-title: EMBO J – volume: 51 start-page: 132 year: 2002 end-page: 139 ident: b0105 article-title: Cocarcinogenic effects of alcohol in hepatocarcinogenesis publication-title: Gut – volume: 42 start-page: 522 year: 2005 end-page: 526 ident: b0050 article-title: Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma publication-title: Hepatology – volume: 24 start-page: 305 year: 2004 end-page: 315 ident: b0030 article-title: Alcohol and hepatitis C publication-title: Semin Liver Dis – volume: 114 start-page: 585 year: 2003 end-page: 598 ident: b0135 article-title: Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells publication-title: Cell – volume: 7 start-page: 861 year: 2007 end-page: 869 ident: b0065 article-title: The impact of a negligent G2/M checkpoint on genomic instability and cancer induction publication-title: Nat Rev Cancer – volume: 33 start-page: 436 year: 2006 end-page: 448 ident: b0225 article-title: Tubulin-associated drug targets: Aurora kinases, Polo-like kinases, and others publication-title: Semin Oncol – volume: 23 start-page: 87 year: 2008 end-page: 91 ident: b0165 article-title: Molecular basis for the synergy between alcohol and hepatitis C virus in hepatocarcinogenesis publication-title: J Gastroenterol Hepatol – volume: 101 start-page: 1309 year: 2004 end-page: 1314 ident: b0045 article-title: Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma publication-title: Proc Natl Acad Sci USA – volume: 131 start-page: 1758 year: 2006 end-page: 1767 ident: b0175 article-title: A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis publication-title: Gastroenterology – volume: 13 start-page: 4955 year: 2007 end-page: 4959 ident: b0115 article-title: Effects of ethanol on hepatic cellular replication and cell cycle progression publication-title: World J Gastroenterol – volume: 44 start-page: 874 year: 1999 end-page: 880 ident: b0035 article-title: Clinical course and risk factors of hepatitis C virus related liver disease in the general population report from the Dionysos study publication-title: Gut – volume: 275 start-page: 77 year: 2009 end-page: 85 ident: b0180 article-title: Aurora-A interacts with cyclin B1 and enhances its stability publication-title: Cancer Lett – volume: 15 start-page: 4753 year: 2009 end-page: 4762 ident: b0210 article-title: Emodin protects rat liver from CCl(4)-induced fibrogenesis via inhibition of hepatic stellate cells activation publication-title: World J Gastroenterol – volume: 51 start-page: 1820 year: 2010 end-page: 1832 ident: b0015 article-title: Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection publication-title: Hepatology – volume: 5 start-page: 1 year: 2007 end-page: 10 ident: b0185 article-title: Roles of aurora kinases in mitosis and tumorigenesis publication-title: Mol Cancer Res – volume: 281 start-page: 10983 year: 2006 end-page: 10989 ident: b0095 article-title: Role of p38 MAPK and RNA-dependent protein kinase (PKR) in Hepatitis C virus core-dependent nuclear delocalization of cyclin B1 publication-title: J Biol Chem – volume: 47 start-page: 7572 year: 2008 end-page: 7582 ident: b0085 article-title: Increased levels of a unique post-translationally modified betaIVb-tubulin isotype in liver cancer publication-title: Biochemistry – volume: 103 start-page: 2248 year: 2008 end-page: 2253 ident: b0125 article-title: Natural course of chronic HCV and HBV infection and role of alcohol in the general population: the Dionysos Study publication-title: Am J Gastroenterol – volume: 124 start-page: 1465 year: 2003 end-page: 1475 ident: b0140 article-title: Expression of hepatitis c virus proteins inhibits interferon alpha signaling in the liver of transgenic mice publication-title: Gastroenterology – volume: 5 start-page: 16 year: 2006 end-page: 24 ident: b0005 article-title: Hepatocellular carcinoma. An overview publication-title: Ann Hepatol – volume: 39 start-page: 227 year: 2007 ident: 10.1016/j.jhep.2010.08.016_b0160 article-title: Emodin negatively affects the phosphoinositide 3-kinase/AKT signalling pathway: a study on its mechanism of action publication-title: Int J Biochem Cell Biol doi: 10.1016/j.biocel.2006.08.006 – volume: 7 start-page: 861 year: 2007 ident: 10.1016/j.jhep.2010.08.016_b0065 article-title: The impact of a negligent G2/M checkpoint on genomic instability and cancer induction publication-title: Nat Rev Cancer doi: 10.1038/nrc2248 – volume: 131 start-page: 1758 year: 2006 ident: 10.1016/j.jhep.2010.08.016_b0175 article-title: A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis publication-title: Gastroenterology doi: 10.1053/j.gastro.2006.09.014 – volume: 24 start-page: 305 year: 2004 ident: 10.1016/j.jhep.2010.08.016_b0030 article-title: Alcohol and hepatitis C publication-title: Semin Liver Dis doi: 10.1055/s-2004-832942 – volume: 275 start-page: 77 year: 2009 ident: 10.1016/j.jhep.2010.08.016_b0180 article-title: Aurora-A interacts with cyclin B1 and enhances its stability publication-title: Cancer Lett doi: 10.1016/j.canlet.2008.10.011 – volume: 44 start-page: 874 year: 1999 ident: 10.1016/j.jhep.2010.08.016_b0035 article-title: Clinical course and risk factors of hepatitis C virus related liver disease in the general population report from the Dionysos study publication-title: Gut doi: 10.1136/gut.44.6.874 – volume: 47 start-page: 2078 year: 2008 ident: 10.1016/j.jhep.2010.08.016_b0055 article-title: Defective DNA strand break repair causes chromosomal instability and accelerates liver carcinogenesis in mice publication-title: Hepatology doi: 10.1002/hep.22194 – volume: 5 start-page: 1 year: 2007 ident: 10.1016/j.jhep.2010.08.016_b0185 article-title: Roles of aurora kinases in mitosis and tumorigenesis publication-title: Mol Cancer Res doi: 10.1158/1541-7786.MCR-06-0208 – volume: 103 start-page: 2248 year: 2008 ident: 10.1016/j.jhep.2010.08.016_b0125 article-title: Natural course of chronic HCV and HBV infection and role of alcohol in the general population: the Dionysos Study publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2008.01948.x – volume: 100 start-page: 1 year: 2009 ident: 10.1016/j.jhep.2010.08.016_b0220 article-title: Molecularly targeted therapy for hepatocellular carcinoma publication-title: Cancer Sci doi: 10.1111/j.1349-7006.2008.01006.x – volume: 5 start-page: 16 year: 2006 ident: 10.1016/j.jhep.2010.08.016_b0005 article-title: Hepatocellular carcinoma. An overview publication-title: Ann Hepatol doi: 10.1016/S1665-2681(19)32034-4 – volume: 59 start-page: 68 year: 2000 ident: 10.1016/j.jhep.2010.08.016_b0170 article-title: Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma publication-title: Oncology doi: 10.1159/000012140 – volume: 19 start-page: 4292 year: 2000 ident: 10.1016/j.jhep.2010.08.016_b0190 article-title: The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin publication-title: EMBO J doi: 10.1093/emboj/19.16.4292 – volume: 127 start-page: 87 year: 2004 ident: 10.1016/j.jhep.2010.08.016_b0010 article-title: Alcohol and hepatocellular carcinoma publication-title: Gastroenterology doi: 10.1053/j.gastro.2004.09.020 – volume: 51 start-page: 1820 year: 2010 ident: 10.1016/j.jhep.2010.08.016_b0015 article-title: Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection publication-title: Hepatology doi: 10.1002/hep.23594 – volume: 38 start-page: 385 year: 2003 ident: 10.1016/j.jhep.2010.08.016_b0100 article-title: Ethanol metabolism results in a G2/M cell-cycle arrest in recombinant Hep G2 cells publication-title: Hepatology doi: 10.1053/jhep.2003.50332 – volume: 281 start-page: 10983 year: 2006 ident: 10.1016/j.jhep.2010.08.016_b0095 article-title: Role of p38 MAPK and RNA-dependent protein kinase (PKR) in Hepatitis C virus core-dependent nuclear delocalization of cyclin B1 publication-title: J Biol Chem doi: 10.1074/jbc.M512536200 – volume: 283 start-page: 28729 year: 2008 ident: 10.1016/j.jhep.2010.08.016_b0145 article-title: Hepatitis B virus X protein increases the Cdt1-to-geminin ratio inducing DNA re-replication and polyploidy publication-title: J Biol Chem doi: 10.1074/jbc.M802751200 – volume: 62 start-page: 627 year: 2010 ident: 10.1016/j.jhep.2010.08.016_b0205 article-title: Dose-dependent hepatoprotective effect of emodin against acetaminophen-induced acute damage in rats publication-title: Exp Toxicol Pathol doi: 10.1016/j.etp.2009.08.006 – volume: 83 start-page: 5718 year: 2009 ident: 10.1016/j.jhep.2010.08.016_b0200 article-title: Protein kinase PKR-dependent activation of mitogen-activated protein kinases occurs through mitochondrial adapter IPS-1 and is antagonized by vaccinia virus E3L publication-title: J Virol doi: 10.1128/JVI.00224-09 – volume: 36 start-page: 1206 year: 2002 ident: 10.1016/j.jhep.2010.08.016_b0040 article-title: Risk factors for hepatocellular carcinoma synergism of alcohol with viral hepatitis and diabetes mellitus publication-title: Hepatology doi: 10.1053/jhep.2002.36780 – volume: 23 start-page: 92 year: 2008 ident: 10.1016/j.jhep.2010.08.016_b0025 article-title: Alcohol, cofactors and the genetics of hepatocellular carcinoma publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.2007.05293.x – volume: 10 start-page: 2065 year: 2004 ident: 10.1016/j.jhep.2010.08.016_b0080 article-title: Overexpression and amplification of Aurora-A in hepatocellular carcinoma publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-1057-03 – volume: 23 start-page: 2016 year: 2004 ident: 10.1016/j.jhep.2010.08.016_b0060 article-title: The spindle checkpoint, aneuploidy, and cancer publication-title: Oncogene doi: 10.1038/sj.onc.1207374 – volume: 47 start-page: 7572 year: 2008 ident: 10.1016/j.jhep.2010.08.016_b0085 article-title: Increased levels of a unique post-translationally modified betaIVb-tubulin isotype in liver cancer publication-title: Biochemistry doi: 10.1021/bi8005225 – volume: 26 start-page: 1201 year: 2007 ident: 10.1016/j.jhep.2010.08.016_b0195 article-title: Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation publication-title: Oncogene doi: 10.1038/sj.onc.1209906 – volume: 33 start-page: 436 year: 2006 ident: 10.1016/j.jhep.2010.08.016_b0225 article-title: Tubulin-associated drug targets: Aurora kinases, Polo-like kinases, and others publication-title: Semin Oncol doi: 10.1053/j.seminoncol.2006.04.007 – volume: 42 start-page: 522 year: 2005 ident: 10.1016/j.jhep.2010.08.016_b0050 article-title: Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma publication-title: Hepatology doi: 10.1002/hep.20847 – volume: 43 start-page: 63 year: 2006 ident: 10.1016/j.jhep.2010.08.016_b0110 article-title: Alcohol and oxidative liver injury publication-title: Hepatology doi: 10.1002/hep.20957 – volume: 13 start-page: 4955 year: 2007 ident: 10.1016/j.jhep.2010.08.016_b0115 article-title: Effects of ethanol on hepatic cellular replication and cell cycle progression publication-title: World J Gastroenterol doi: 10.3748/wjg.v13.i37.4955 – volume: 16 start-page: 41 year: 2005 ident: 10.1016/j.jhep.2010.08.016_b0150 article-title: Regulatory effects of emodin on NF-kappaB activation and inflammatory cytokine expression in RAW 264.7 macrophages publication-title: Int J Mol Med doi: 10.1007/s00894-004-0218-5 – volume: 28 start-page: 175 year: 2008 ident: 10.1016/j.jhep.2010.08.016_b0020 article-title: Viral hepatocarcinogenesis: from infection to cancer publication-title: Liver Int doi: 10.1111/j.1478-3231.2007.01652.x – volume: 120 start-page: 2987 year: 2007 ident: 10.1016/j.jhep.2010.08.016_b0130 article-title: Aurora-A: the maker and breaker of spindle poles publication-title: J Cell Sci doi: 10.1242/jcs.013136 – volume: 124 start-page: 1465 year: 2003 ident: 10.1016/j.jhep.2010.08.016_b0140 article-title: Expression of hepatitis c virus proteins inhibits interferon alpha signaling in the liver of transgenic mice publication-title: Gastroenterology doi: 10.1016/S0016-5085(03)00290-7 – volume: 2 start-page: 41 year: 2006 ident: 10.1016/j.jhep.2010.08.016_b0120 article-title: HCV-related transformation and new therapeutic strategies: an update publication-title: Curr Cancer Ther Rev doi: 10.2174/157339406775471830 – volume: 51 start-page: 132 year: 2002 ident: 10.1016/j.jhep.2010.08.016_b0105 article-title: Cocarcinogenic effects of alcohol in hepatocarcinogenesis publication-title: Gut doi: 10.1136/gut.51.1.132 – volume: 101 start-page: 1309 year: 2004 ident: 10.1016/j.jhep.2010.08.016_b0045 article-title: Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0305817101 – volume: 17 start-page: 1041 year: 2006 ident: 10.1016/j.jhep.2010.08.016_b0070 article-title: Microtubule regulation in mitosis: tubulin phosphorylation by the cyclin-dependent kinase Cdk1 publication-title: Mol Biol Cell doi: 10.1091/mbc.E05-07-0621 – volume: 205 start-page: 25 year: 2005 ident: 10.1016/j.jhep.2010.08.016_b0090 article-title: Thr 446 phosphorylation of PKR by HCV core protein deregulates G2/M phase in HCC cells publication-title: J Cell Physiol doi: 10.1002/jcp.20363 – volume: 392 start-page: 473 year: 2010 ident: 10.1016/j.jhep.2010.08.016_b0215 article-title: Emodin inhibits the growth of hepatoma cells: finding the common anti-cancer pathway using Huh7, Hep3B, and HepG2 cells publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2009.10.153 – volume: 114 start-page: 585 year: 2003 ident: 10.1016/j.jhep.2010.08.016_b0135 article-title: Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells publication-title: Cell doi: 10.1016/S0092-8674(03)00642-1 – volume: 23 start-page: 87 year: 2008 ident: 10.1016/j.jhep.2010.08.016_b0165 article-title: Molecular basis for the synergy between alcohol and hepatitis C virus in hepatocarcinogenesis publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.2007.05292.x – volume: 66 start-page: 5807 year: 2006 ident: 10.1016/j.jhep.2010.08.016_b0155 article-title: Emodin inhibits tumor cell adhesion through disruption of the membrane lipid Raft-associated integrin signaling pathway publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-06-0077 – volume: 59 start-page: 68 issue: 1 year: 2000 ident: 10.1016/j.jhep.2010.08.016_b0075 article-title: Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma publication-title: Oncology doi: 10.1159/000012140 – volume: 15 start-page: 4753 year: 2009 ident: 10.1016/j.jhep.2010.08.016_b0210 article-title: Emodin protects rat liver from CCl(4)-induced fibrogenesis via inhibition of hepatic stellate cells activation publication-title: World J Gastroenterol doi: 10.3748/wjg.15.4753 |
SSID | ssj0003094 |
Score | 2.0810077 |
Snippet | Chromosomal aberrations are frequently observed in hepatitis C virus (HCV)- and alcohol-related hepatocellular carcinomas (HCCs). The mechanisms by which... Background & Aims Chromosomal aberrations are frequently observed in hepatitis C virus (HCV)- and alcohol-related hepatocellular carcinomas (HCCs). The... |
SourceID | proquest pubmed pascalfrancis crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 956 |
SubjectTerms | Aurora Kinase A Aurora Kinases Biological and medical sciences Biopsy Carcinoma, Hepatocellular - metabolism Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - virology Central Nervous System Depressants - metabolism Central Nervous System Depressants - pharmacology Cyclin B1 Cyclin B1 - metabolism Drug Interactions Emodin - metabolism Emodin - pharmacology Ethanol Ethanol - metabolism Ethanol - pharmacology Gastroenterology and Hepatology Gastroenterology. Liver. Pancreas. Abdomen HCC HCV Hep G2 Cells Hepatitis C, Chronic - metabolism Hepatitis C, Chronic - pathology Humans In Vitro Techniques Liver Diseases, Alcoholic - complications Liver Diseases, Alcoholic - metabolism Liver Diseases, Alcoholic - pathology Liver Neoplasms - metabolism Liver Neoplasms - pathology Liver Neoplasms - virology Liver. Biliary tract. Portal circulation. Exocrine pancreas Medical sciences Mitosis - physiology Phosphorylation - physiology Protein Kinase Inhibitors - metabolism Protein Kinase Inhibitors - pharmacology Protein-Serine-Threonine Kinases - metabolism Signal Transduction - physiology Tubulin - metabolism Tumors |
Title | Hepatitis C virus and alcohol: Same mitotic targets but different signaling pathways |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0168827810009165 https://www.clinicalkey.es/playcontent/1-s2.0-S0168827810009165 https://dx.doi.org/10.1016/j.jhep.2010.08.016 https://www.ncbi.nlm.nih.gov/pubmed/21145809 https://www.proquest.com/docview/862600305 |
Volume | 54 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhhVIoJelzm2bRobfirGxJlp1bWBq2aRNKk0BuQivJdEPjLJG3pZf89s6s5A2haQI9GYwG2-N5fJK-0RDyHkBuIUrGs2nlbCa8KrOKNzyzjkvODOZ03NE9PConp-LgTJ6tkXFfC4O0yhT7Y0xfRut0Z5S0OZrPZqNjACsAD1WFK9QAcrDQXAiFVr5zfUPz4KxO53tXGY5OhTOR43X-3c8TvavaYdjz_O7k9HRuAqisib0u_g1Gl0lpf4M8S2iS7sUX3iRrvn1OHh-m_fIX5GTikTHdzQId05-zq0WgpnXUxL64u_TYXHh6AU4N8jSSwgOdLjra903pKBI8DNasU2xe_Mv8Di_J6f7Hk_EkS30UMiul6jKfN8zkilkD2cg1gAmMVKIWjfQWcpVztvAWYI3Ka6GsyJn1ZamasrAWXF45_oqst5etf0OobdxUOOkKy2sBwaDC49cQA_qSc1_lA5L3CtQ2HTKOvS5-6J5Ndq5R6RqVrrEBZl4OyIeVzDwesXHvaN7_F90Xj0K405AB7pVSd0n5kDw26FyHQjP9l1UNiFxJ3jLMB584vGU0q0_DKTTnNQygvRVpcGncpzGtv1wEvZxkYiAekNfRum6EYfoqK1a__c-32iJP4qI4MjbfkfXuauG3AVV10-HSbYbk0d7425eveP30eXL0B2l1H54 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED-6FLbBKPvsso9OD3sbXmzLsuy9lbDirk1emkLfhCLJLKV1Q-1s7L_fXSSnlHUd7NXosHy-j5-kn-4APiLITbM85tG8sCbKnMyjgtc8MpYLHmvK6XSiO5nm1Wn27UycbcG4vwtDtMoQ-31MX0fr8GQUtDlaLhajEwQrCA9lQTvUCHLEA9im6lRiANv7h0fVdBOQeVyGEt9FRALh7oyneZ1_d8vA8Co-x9T2_O789GSpW9Ra7dtd_B2PrvPSwVPYCYCS7fs5P4Mt1zyHh5NwZP4CZpUj0nS3aNmY_Vhcr1qmG8u0b437hZ3oS8cu0a9RnnleeMvmq471rVM6RhwPTdfWGfUv_ql_tS_h9ODrbFxFoZVCZISQXeSSOtaJjI3GhGRrhAVayKzMauEMpitrTeoMIhuZlJk0WRIbl-eyzlNj0Oul5a9g0Fw17jUwU9t5ZoVNDS8zjAcFVWAjGOhyzl2RDCHpFahMqDNO7S4uVE8oO1ekdEVKV9QDM8mH8Gkjs_RVNu4dzfv_ovr7oxjxFCaBe6XkXVKuDU7bqkS1qYrVH4Y1BLGRvGWb_3zj3i2j2XwaraI5L3EA661IoVfTUY1u3NWqVet1JsXiIex667oRxhWsKOLyzX_O6gM8qmaTY3V8OD16C4_9HjkRON_BoLteufcIsrr5XnCi3zODILo |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hepatitis+C+virus+and+alcohol%3A+Same+mitotic+targets+but+different+signaling+pathways&rft.jtitle=Journal+of+hepatology&rft.au=Alisi%2C+Anna&rft.au=Ghidinelli%2C+Monica&rft.au=Zerbini%2C+Alessandro&rft.au=Missale%2C+Gabriele&rft.date=2011-05-01&rft.issn=0168-8278&rft.volume=54&rft.issue=5&rft.spage=956&rft.epage=963&rft_id=info:doi/10.1016%2Fj.jhep.2010.08.016&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jhep_2010_08_016 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01688278%2FS0168827811X00028%2Fcov150h.gif |